scholarly article | Q13442814 |
P2093 | author name string | Miller M | |
Pearson TA | |||
Seidler A | |||
Moalemi A | |||
P2860 | cites work | Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol | Q33896856 |
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies | Q34496492 | ||
Hypertriglyceridemic Very Low Density Lipoproteins Induce Triglyceride Synthesis and Accumulation in Mouse Peritoneal Macrophages | Q36985479 | ||
Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease | Q39241018 | ||
The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics | Q39743407 | ||
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients | Q42556657 | ||
Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events | Q43891430 | ||
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. | Q44689759 | ||
Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. | Q44759552 | ||
Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). | Q45208371 | ||
Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin | Q46176091 | ||
Hyperlipoproteinemia and pancreatitis | Q48014923 | ||
Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. | Q50926556 | ||
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. | Q51603418 | ||
Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. | Q51621111 | ||
Hyperapobetalipoproteinemia. Plasma lipoprotein responses to oral fat load. | Q51633932 | ||
Long-term prognosis after myocardial infarction in men with diabetes. | Q52664903 | ||
Premature Atherosclerosis in Patients with Familial Chylomicronemia Caused by Mutations in the Lipoprotein Lipase Gene | Q57840093 | ||
A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis | Q57840099 | ||
The veterans affairs high-density lipoprotein intervention trial: Baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterol | Q61785739 | ||
A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association | Q66912818 | ||
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment | Q67720940 | ||
Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study | Q68037615 | ||
Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged < or = 50 years) and women (< or = 60 years) with coronary artery disease | Q70595052 | ||
Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes | Q71102944 | ||
Serum triglycerides in health and in ischemic heart disease | Q72559601 | ||
Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis | Q72791703 | ||
Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group | Q73804303 | ||
Serum triglycerides in coronary artery disease | Q78455521 | ||
Influence of myocardial infarction on plasma-lipoprotein concentration | Q78705437 | ||
Are we mortgaging the medical profession? | Q95814757 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | triglyceride | Q186319 |
coronary artery disease | Q844935 | ||
P304 | page(s) | 1252-1257 | |
P577 | publication date | 1998-05-01 | |
P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
P1476 | title | Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study. | |
P478 | volume | 31 |
Q34145532 | A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans |
Q37262617 | Adipose tissue dysfunction in obesity, diabetes, and vascular diseases |
Q37035456 | Age- and sex-related changes in fasting plasma glucose and lipoprotein in cynomolgus monkeys |
Q44451305 | An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia |
Q44559866 | Antihypertriglyceridemic effect of walnut oil. |
Q92547414 | Association between normal triglyceride and insulin resistance in US adults without other risk factors: a cross-sectional study from the US National Health and Nutrition Examination Survey, 2007-2014 |
Q34107165 | Combination drug therapy for dyslipidemia. |
Q40393652 | Coronary heart disease in women: what do we know now? |
Q33835502 | Dietitian intervention improves lipid values and saves medication costs in men with combined hyperlipidemia and a history of niacin noncompliance |
Q34262629 | Differentiating the effects of raising low levels of high-density lipoprotein cholesterol versus lowering normal triglycerides: further insights from the Veterans Affairs High-Density Lipoprotein Intervention Trial |
Q32063032 | Distribution and cardiovascular risk correlates of serum triglycerides in young adults from a biracial community: the Bogalusa Heart Study |
Q51552229 | Diurnal triglyceride profiles in healthy normolipidemic male subjects are associated to insulin sensitivity, body composition and diet. |
Q32063040 | Diurnal triglyceride profiles: a novel approach to study triglyceride changes |
Q37143825 | Do Estrogen Receptor beta Polymorphisms Play A Role in the Pharmacogenetics of Estrogen Signaling? |
Q46199518 | Drug therapy for hypertriglyceridemia: fibrates and omega-3 fatty acids |
Q44311057 | Effect of desirable fasting triglycerides on the postprandial response to dietary fat. |
Q31919769 | Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production |
Q51457652 | Effects of a 1,3-diacylglycerol oil-enriched diet on postprandial lipemia in people with insulin resistance. |
Q85181665 | Effects of a diet with inulin-enriched pasta on gut peptides and gastric emptying rates in healthy young volunteers |
Q37328559 | Effects of feeding periods of high cholesterol and saturated fat diet on blood biochemistry and hydroxyproline fractions in rabbits |
Q44007594 | Epidemiology of hypertriglyceridemia and cardiovascular disease |
Q34071541 | Evidence that triglycerides are an independent coronary heart disease risk factor |
Q51298164 | Fasting Lipoprotein Lipase Protein Levels Can Predict a Postmeal Increment of Triglyceride Levels in Fasting Normohypertriglyceridemic Subjects. |
Q44536731 | Fasting and daylong triglycerides in obesity with and without type 2 diabetes |
Q44054654 | Frequency of postprandial lipemia after a first acute coronary event (unstable angina pectoris or non-ST-segment elevation acute myocardial infarction) and the effects of atenolol on the lipemia |
Q77463131 | Gender differences in diurnal triglyceridemia in lean and overweight subjects |
Q37997627 | Genetically modified pigs for biomedical research. |
Q33972829 | Giving triglycerides their due. |
Q51369235 | Hemostatic effects of bezafibrate and ω-3 fatty acids in isolated hypertriglyceridemic patients. |
Q41480218 | High postprandial triglycerides serum levels: is obesity a good predictor? |
Q43913029 | Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: triglycerides and blood viscosity |
Q30244825 | Hypertriglyceridemia: the importance of identifying patients at risk |
Q33580249 | Impact of admission triglyceride for early outcome in diabetic patients with stable coronary artery disease |
Q33646056 | Impact of dyslipidaemia. Lessons from clinical trials |
Q44341495 | Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart disease |
Q36569199 | Interlinkage among cardio-metabolic disease markers in an urban poor setting in Nairobi, Kenya |
Q34084615 | Introduction: low-saturated fat, high-carbohydrate diets: effects on triglyceride and LDL synthesis, the LDL receptor, and cardiovascular disease risk |
Q44173620 | Inulin-enriched pasta affects lipid profile and Lp(a) concentrations in Italian young healthy male volunteers. |
Q44621116 | Life Style and Cardiovascular Risk Factors in the Japanese Population-From an Epidemiological Survey on Serum Lipid Levels in Japan 1990. Part 1: Influence of Life Style and Excess Body Weight on HDL-Cholesterol and Other Lipid Parameters in Men |
Q44621121 | Life Style and Cardiovascular Risk Factors in the Japanese Population-From an Epidemiological Survey on Serum Lipid Levels in Japan 1990. Part 2: Association of Lipid Parameters with Hypertension |
Q36070412 | Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis |
Q35203793 | Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment |
Q35101119 | Management of patients with diabetic hyperlipidemia |
Q33843614 | Management of selected lipid abnormalities. Hypertriglyceridemia, low HDL cholesterol, lipoprotein(a), in thyroid and renal diseases, and post-transplantation |
Q35108901 | Nutrition for health promotion: phytochemicals, functional foods, and alternative approaches to combat obesity |
Q34129395 | Orphan nuclear hormone receptor Rev-erbalpha regulates the human apolipoprotein CIII promoter |
Q79762017 | Overproduction of intestinal lipoprotein containing apolipoprotein B-48 in Psammomys obesus: impact of dietary n-3 fatty acids |
Q33918549 | Pharmacodynamics of oestrogens and progestogens |
Q34003407 | Preventing, stopping, or reversing coronary artery disease--triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: the need for recognition and treatment |
Q34418506 | Psoriasis and comorbidities: links and risks |
Q46386834 | Psoriasis and dyslipidemia: a population-based study analyzing the National Health and Nutrition Examination Survey (NHANES). |
Q33646061 | Resource utilisation in the management of dyslipidaemia |
Q31942452 | Safety and effectiveness of Niaspan when added sequentially to a statin for treatment of dyslipidemia |
Q52538514 | Serum neopterin and complex stenosis morphology in patients with unstable angina. |
Q28208349 | Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism |
Q44272184 | Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes |
Q94278550 | Sugar |
Q28199120 | The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response Element |
Q38056160 | The association between psoriasis and dyslipidaemia: a systematic review |
Q33748893 | The changes in various hydroxyproline fractions in aortic tissue of rabbits are closely related to the progression of atherosclerosis |
Q35332645 | The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia |
Q33665230 | The epidemiology of triglyceride as a coronary artery disease risk factor |
Q58271154 | The metabolic syndrome and cardiovascular disease |
Q37308002 | The role of triglycerides in cardiovascular risk |
Q44469664 | Triglyceride as a risk factor, epidemiology |
Q34027254 | Triglycerides and coronary risk |
Q34418028 | Uses and benefits of omega-3 ethyl esters in patients with cardiovascular disease. |
Q46727396 | Walnut consumption in hyperlipidemic patients. |
Search more.